Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02182180 · ClinicalTrials.gov registry record

SC2i Tissue and Data Repository Protocol

A clinical trial of Critical Illness, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Recruiting
Registry status
5,000
Enrollment target
4
Study locations

NCT02182180 is a study of Critical Illness that is actively recruiting participants, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 5,000 participants, above the 3,083-participant average among 91 other Critical Illness trials with a reported enrollment target (62% higher). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02182180, a study of Critical Illness, is actively recruiting participants, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

RECRUITING
Registry status
5,000 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill. The samples will be used to develop and assess tests and/or tools that doctors can use to decide the best treatment plan for seriously injured or ill military personnel and for civilians. Additonal protocols to use the samples will be submitted as separate protocols.

Conditions Studied

Study Locations (4)

Georgia

  • Grady Health Systems - Atlanta
  • Emory University - Atlanta

Maryland

  • Walter Reed National Military Medical Center - Bethesda

North Carolina

  • Duke University Health Systems - Durham

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2014-09-09
Est. Completion 2027-08

What the Registry Record Tells You About NCT02182180

The ClinicalTrials.gov registry entry for NCT02182180 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,083-participant average among 91 other Critical Illness trials with a reported enrollment target (62% higher). The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.

NCT02182180 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02182180 about?

NCT02182180 is a clinical study titled "SC2i Tissue and Data Repository Protocol". The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill. The samples will be used to develop ...

What is the current status of trial NCT02182180?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2014-09-09. Estimated completion is 2027-08.

What conditions does trial NCT02182180 study?

This clinical trial studies the following conditions: Critical Illness.

Who is sponsoring clinical trial NCT02182180?

This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02182180 being conducted?

This trial has 4 study locations across Georgia, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.